Revvity, Inc. (NYSE:RVTY) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Revvity, Inc. (NYSE:RVTY - Get Free Report) has received an average recommendation of "Moderate Buy" from the thirteen research firms that are currently covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $136.25.

Several equities analysts have recently issued reports on RVTY shares. Barclays boosted their price objective on Revvity from $135.00 to $140.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Bank of America raised Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price target for the company in a report on Friday, December 13th. Raymond James reaffirmed an "outperform" rating and issued a $145.00 price target (up previously from $140.00) on shares of Revvity in a report on Monday, February 3rd. Sanford C. Bernstein cut Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target for the company. in a report on Friday, January 10th. Finally, KeyCorp upped their price target on Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd.

Revvity Stock Performance

RVTY traded up $4.74 on Thursday, reaching $117.95. 1,399,074 shares of the stock were exchanged, compared to its average volume of 935,202. The company's 50-day moving average price is $116.90 and its 200 day moving average price is $118.23. Revvity has a fifty-two week low of $97.32 and a fifty-two week high of $129.50. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The firm has a market capitalization of $14.17 billion, a PE ratio of 53.37, a PEG ratio of 3.82 and a beta of 1.06.

Remove Ads

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, topping analysts' consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same quarter in the previous year, the company posted $1.25 earnings per share. As a group, sell-side analysts forecast that Revvity will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.24%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity's dividend payout ratio (DPR) is 12.67%.

Insiders Place Their Bets

In other Revvity news, insider Tajinder S. Vohra sold 5,492 shares of the company's stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total transaction of $641,520.52. Following the transaction, the insider now directly owns 19,652 shares in the company, valued at $2,295,550.12. This represents a 21.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the transaction, the insider now owns 33,400 shares in the company, valued at $4,232,782. This trade represents a 31.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.60% of the stock is owned by insiders.

Institutional Trading of Revvity

Several hedge funds have recently modified their holdings of the stock. Dogwood Wealth Management LLC raised its stake in shares of Revvity by 16.8% in the fourth quarter. Dogwood Wealth Management LLC now owns 4,987 shares of the company's stock valued at $557,000 after acquiring an additional 717 shares in the last quarter. Siemens Fonds Invest GmbH increased its holdings in Revvity by 264.8% in the fourth quarter. Siemens Fonds Invest GmbH now owns 13,357 shares of the company's stock valued at $1,491,000 after buying an additional 9,696 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Revvity in the fourth quarter valued at $16,293,000. Vermillion Wealth Management Inc. purchased a new position in Revvity in the fourth quarter valued at $41,000. Finally, Mackenzie Financial Corp increased its holdings in Revvity by 22.3% in the fourth quarter. Mackenzie Financial Corp now owns 14,381 shares of the company's stock valued at $1,605,000 after buying an additional 2,619 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.